查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466557

中心实验室市场：按服务类型、阶段、治疗领域和最终用途分类 - 全球预测 2024-2030

Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年中心实验室市场规模为31.1亿美元，预计2024年将达33.8亿美元，2030年将达57.8亿美元，复合年增长率为9.25%。

中心实验室作为卓越中心，为世界各地的各种临床试验设施提供高品质、标准化的检测服务。这些实验室在确保资料完整性、一致性和可靠性方面发挥着至关重要的作用，这是有效临床研究和开发的先决条件。由于对专业检测服务的需求不断增长、全球临床试验的激增以及製药行业对外包以提高效率和专注于核心能力的重视，对中心实验室的需求也在不断增长。然而，製药业面临营运成本高、监管复杂、全球营运标准化等挑战。中央实验室透过利用技术进步、建立策略合作伙伴关係和加强其地理影响力来解决这些限制，以提供本地服务，同时保持国际标准。生物标记服务的扩展、个人化医疗以及预测分析人工智慧的整合标誌着 Central Lab 在不断发展的临床研究领域的发展轨迹。

主要市场统计
基准年[2023] 31.1亿美元
预测年份 [2024] 33.8亿美元
预测年份 [2030] 57.8亿美元
复合年增长率（%） 9.25%

服务类型 优先选择中央实验室，在受控条件下长期储存生物样本以进行特定管理

解剖病理学和组织学服务包括检查身体组织以发现疾病。这些服务对于诊断各种类型的癌症和慢性病至关重要。生物标记服务可辨识组织、血液和其他体液中的生物标记，以诊断疾病、监测疾病进展并预测治疗效果。遗传服务提供基于 DNA 的检测，包括序列测定和基因分型，以识别遗传疾病、易感性和疾病携带者状态。微生物学服务对于识别和表征微生物以预防和治疗感染疾病至关重要。中心实验室确保这些程序的安全性并遵守全球卫生法规。专业化学服务进行复杂的生化分析，以检测荷尔蒙失衡、营养缺乏和有害物质。检体管理和储存服务确保用于研究和诊断的生物样本的完整性。中心实验室提供专业化学服务和用于检体管理的安全检体储存解决方案。

中心实验室在整个临床试验过程中的关键作用

中心实验室在临床试验各个阶段的成功和管理中发挥着至关重要的作用。实验室的参与可确保测试结果的准确性、可靠性和标准化，这对于监管核准流程和整个临床开发计划的成功至关重要。第一阶段的重点在于评估药物的安全性，中心实验室利用生物样本评估药物的药物动力学（PK）、动态（PD），并监测不利事件的收集和分析。中心实验室的标准化流程以最高精度评估药物的初始安全性，并促进无缝过渡到下一阶段。在第二阶段，中心实验室将继续评估药物的安全性，同时开始评估对更多患有相关疾病或病症的患者群体的疗效。为了衡量药物的有效性并更好地了解其作用机制，通常会进行更复杂的分析，包括多种生物标记和专门测试。中心实验室现阶段所获得的资料对于规划3期试验至关重要。第三阶段涉及大规模试验，以证明该药物的有效性并监测不同人群的副作用。中央实验室管理在多个国际站点创建的大量资料。儘管分布广泛，中央实验室的全球网路和严格的品管通讯协定确保了结果的一致性和标准化。这种一致性对于监管提交至关重要。此外，中心实验室在长期药物监测、评估现实世界的疗效和安全性方面发挥着重要作用。进行专门的试验并收集可以识别罕见副作用和益处的资料可以导致标籤的变化和临床实践指南的调整。

最终用途：必须促进无缝临床试验并确保製药公司的资料完整性和卓越营运。

学术研究机构主要利用研究服务来推广科学研究和实现教育目标。他们的主要目的是利用先进的分析能力和技术，而这些能力和技术通常在经济上无法在内部维护。这些实验室优先考虑高品质、准确的结果和技术主导的解决方案，以支持从生物医学研究到环境调查的各种研究项目。病理学和诊断实验室经常利用中心实验室进行高级测试，由于设备成本和专业知识的需要，这些测试很难在内部进行。与中央实验室的合作使诊断病理学实验室能够透过提供高通量测试技术并确保测试品质和可靠性来满足快速週转时间的需求。生技公司，尤其是处于早期和开发阶段的生技公司，希望中央实验室能够扩大其研发能力，而无需对自己的设施进行大量投资。对于这些公司来说，不同司法管辖区的周转时间、扩充性和监管合规性方面的专业知识至关重要。他们通常需要专业服务，例如生物标记开发、细胞/基因治疗评估和个人化医疗支援。製药公司在整个药物开发週期（从药物发现到上市后监督）广泛使用中央实验室服务。关键考虑因素包括全球企业发展、物流能力、资料管理能力以及监管合规记录。 Central Lab Pharmaceuticals 专注于支援多中心、全球临床试验的端到端解决方案。

癌症和感染疾病治疗领域的综合诊断和预后测试

中心实验室检测服务透过促进临床试验各阶段的准确和标准化检测，在推进和支持治疗领域方面发挥着至关重要的作用。中心实验室口语服务在多个关键领域发挥着重要作用，显着影响治疗方法和推进医学知识。这些实验室为自体免疫疾病提供准确诊断和疾病管理的基本服务，包括自体抗体分析和细胞激素分析。在对抗心血管疾病的过程中，评估心血管生物标记物，例如脂质谱和心肌损伤标记物，有助于早期发现和优化患者照护。中心实验室的能力对于感染疾病控制也至关重要，它提供了控制疫情和评估治疗性介入所需的先进诊断和监测工具。对于神经系统疾病，生物标记特异性测试可以深入了解阿兹海默症和帕金森氏症等疾病，支持早期诊断和新治疗方法。此外，在肿瘤学领域，中心实验室提供肿瘤标记分析、基因组分析等全面的诊断和预后检测，推动个人化医疗的进步。中心实验室的标准化和先进服务是改善病患治疗效果和加速这些关键治疗领域的医学研究的基础。

区域洞察

在美洲，在临床试验激增和强大的研发基础设施的推动下，中心实验室市场呈现强劲成长。先进诊断和生物标记开发的重要性日益增加，正在加速对美洲中心实验室的投资。在医疗保健投资增加、对监管合规性的日益关注以及促进技术转移和能力建设的全球战略合作伙伴关係的推动下，亚太地区以其快速扩张而脱颖而出。向精准医学的转变为亚太地区充满活力且相互关联的全球中心实验室生态系统奠定了基础。欧洲、中东和非洲是一个发达的市场，拥有严格的监管架构和高度统一的检验实践。该地区受益于药物研究的历史、高技能的劳动力和创新，特别是在个人化医疗方面。

FPNV定位矩阵

FPNV定位矩阵对于评估Central Lab市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对中央实验室市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 中心实验室市场的市场规模与预测是多少？

2.在中心实验室市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3. 中心实验室市场的技术趋势和法规结构是什么？

4.中心实验室市场主要厂商的市场占有率是多少？

5. 进入中心实验室市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 临床试验数量不断增加，药物开发活动的复杂性不断增加
      • 政府在全球推广精准医疗的倡议
    • 抑制因素
      • 建立和维护中心实验室的成本很高。
    • 机会
      • 中心实验室的技术整合和智慧功能
      • 投资建立与扩大中心实验室
    • 任务
      • 操作限制和标准化复杂性
  • 市场区隔分析
    • 服务类型：优先选择中心实验室在受控条件下长期保存生物样本进行专门管理
    • 阶段：中心实验室在整个临床试验过程执行中的关键作用
    • 最终用途：必须促进无缝临床试验，同时确保製药公司的资料和卓越运营
    • 治疗领域：肿瘤和感染疾病治疗领域的综合诊断和预后检测
  • 市场趋势分析
    • 利用先进的资料分析整合提高整个美洲中心实验室的效率
    • 亚太全部区域临床试验显着增加，活性化政府投资和扩大中心化验服务
    • 欧洲、中东和非洲地区临床试验生物样本收集的严格规定以及医学实验室之间战略合作的探索
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章 中心实验室市场：依服务类型

  • 解剖病理学/组织学
  • 生物标誌服务
  • 遗传服务
  • 微生物学服务
  • 特种化学品服务
  • 标本管理及储存

第七章 中心实验室市场分阶段

  • 阶段1
  • 阶段2
  • 第三阶段

第八章依治疗领域分類的中心实验室市场

  • 自体免疫疾病
  • 心血管疾病
  • 感染疾病
  • 神经病学
  • 肿瘤学

第 9 章 中心实验室市场：依最终用途分类

  • 学术研究所
  • 生技公司
  • 病理学和诊断实验室
  • 製药公司

第10章美洲的中心实验室市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太中心实验室市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的中心实验室市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Medpace 中央实验室扩建新加坡工厂
    • Vial 宣布与 MLM Medical Labs 合作提供中央测试解决方案
    • Cerba Healthcare 收购加拿大合约研究机构 CIRION BioPharma Research，以扩大生物分析能力并减少进行复杂临床试验的时间
    • 克利夫兰诊所和 LabConnect 宣布建立策略联盟以改善患者照护
    • Versiti 收购总部位于印第安纳州的 Quantigen，以加速临床前研究服务的创新
    • Wispringhof 职业医学大学与 Labconnect 宣布策略合作伙伴关係—扩大全球中心实验室服务以加速药物开发
    • IQVIA 和 (RED) 宣布建立突破性合作伙伴关係，帮助增强实验室系统
    • Cerba Investigations 为化验服务合作伙伴提供客製化和创新的方法
    • Medpace 中心实验室扩大组织学和解剖病理学服务
    • Thermo Fisher 投资 5,900 万美元扩大美国临床研究实验室

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-F927BA462EBB

[182 Pages Report] The Central Lab Market size was estimated at USD 3.11 billion in 2023 and expected to reach USD 3.38 billion in 2024, at a CAGR 9.25% to reach USD 5.78 billion by 2030.

A central lab operates as a core facility providing high-quality and standardized testing services across various clinical trial sites globally. These labs are pivotal for ensuring data integrity, consistency, and reliability, a prerequisite for effective clinical research and development. The increasing need for specialized testing services, the surge in clinical trials worldwide, and the pharmaceutical industry's emphasis on outsourcing to enhance efficiency and focus on core competencies are expanding the need for central labs. However, the sector faces restraints such as high operational costs, regulatory complexities, and the challenge of maintaining standardization across global operations. Central labs leverage technological advancements, establish strategic partnerships, and enhance their geographical presence to provide localized services while maintaining international standards to address these restraints. The expansion of biomarker services, personalized medicine, and the integration of artificial intelligence for predictive analysis are setting a trajectory for central labs in the evolving clinical research landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 3.11 billion
Estimated Year [2024] USD 3.38 billion
Forecast Year [2030] USD 5.78 billion
CAGR (%) 9.25%

Services Type: Preference for central labs for long-term storage of biological samples under controlled conditions for specific management

Anatomic pathology and histology services encompass examining bodily tissues to detect diseases. These services are vital for diagnosing various types of cancers and chronic diseases. Biomarker services focus on identifying biological markers in tissues, blood, and other body fluids to diagnose diseases, monitor disease progression, and predict treatment response. Genetic services provide DNA-based testing, including sequencing and genotyping, to identify genetic disorders, predispositions, and carrier statuses for diseases. Microbiology services are essential for identifying and characterizing microorganisms to prevent and treat infections. Central labs ensure the safety and compliance of these procedures with health regulations stated worldwide. Special chemistry services involve complex biochemical analyses to detect hormonal imbalances, nutritional deficiencies, and toxic substances. Specimen management and storage services ensure the integrity of biological samples for research and diagnostics. Central labs offer secure sample storage solutions for specialty chemical services and specimen management.

Phase: Integral role of the central labs for the execution of the entire clinical trial process

Central laboratories play a pivotal role in the successful execution and management of clinical trials across all phases. Their involvement ensures the accuracy, reliability, and standardization of laboratory results, which are essential for the regulatory approval process and the overall success of the clinical development program. In Phase I, the primary focus is on assessing a drug's safety, where central labs collect and analyze biological samples to evaluate the drug's pharmacokinetics (PK), pharmacodynamics (PD), and monitor adverse events. Their standardized processes ensure that the early safety profile of the drug is assessed with the highest accuracy, facilitating a seamless transition to the subsequent phase. During Phase 2, central labs continue to assess the drug's safety while beginning to evaluate its efficacy in a larger patient population with the targeted disease or condition. They perform more complex analyses, often involving multiple biomarkers and specialized tests to measure the drug's effect and further understand its mechanism of action. The data generated by central labs at this stage are critical for planning Phase 3 studies. Phase 3 involves large-scale testing to conclusively demonstrate the drug's efficacy and monitor its side effects in diverse populations. Central labs manage a vast amount of data generated across multiple international sites. Despite the geographical spread, they ensure consistency and standardization of results through their global network and stringent quality control protocols. This uniformity is crucial for regulatory submissions. Moreover, central labs play a vital role in long-term drug surveillance, assessing its real-world effectiveness and safety profile. They conduct specialized tests and gather data that can identify rare side effects or benefits, which may result in label changes or adjustments in clinical practice guidelines.

End-use: Need to facilitate seamless clinical trials, ensuring data integrity and operational excellence for pharmaceutical companies

Academic and research institutes predominantly engage central lab services to advance scientific research and fulfill their educational objectives. The primary focus lies in getting access to advanced analytical capabilities and technologies, which often are not financially feasible to maintain in-house. These institutes prioritize high-quality, accurate results and technology-driven solutions to support various research programs ranging from biomedical research to environmental studies. Pathology and diagnostic labs often leverage central labs for advanced tests that are not feasible to conduct in-house due to the cost of equipment or the need for specialized expertise. Collaborating with central labs allows pathology and diagnostic labs to meet the demand for rapid turnaround times by providing access to high-throughput testing technologies, ensuring the quality and reliability of the tests. Biotechnology companies, especially those in the early and developmental stages, look to central laboratories to extend their R&D capabilities without substantial investment in in-house facilities. For these entities, turnaround time, scalability, and expertise in regulatory compliance across different jurisdictions are vital. They often require specialized services such as biomarker development, cell and gene therapy assessments, and personalized medicine support. Pharmaceutical companies utilize central laboratory services extensively across the drug development cycle, from discovery through post-market surveillance. Their key considerations include global footprint, logistical prowess, data management capabilities, and a proven track record in regulatory compliance. The central lab pharmaceutical companies emphasize end-to-end solutions that can support multi-centric, global clinical trials.

Therapeutic Area: Comprehensive diagnostic and prognostic testing for oncology and infectious diseases therapeutic areas

Central laboratory services play a pivotal role in advancing and supporting therapeutic areas, facilitating precise and standardized testing across various stages of clinical trials. The central laboratory services play an indispensable role across various key areas, significantly influencing treatment modalities and advancing medical knowledge. These labs provide essential services for autoimmune diseases, such as autoantibody profiling and cytokine analysis, which are critical for accurate diagnosis and disease management. In tackling cardiovascular diseases, assessing cardiovascular biomarkers, including lipid profiles and cardiac injury markers, facilitates early detection and patient care optimization. Central labs' capabilities are also pivotal in infectious disease management, offering advanced diagnostic and monitoring tools essential for controlling outbreaks and evaluating therapeutic interventions. When examining neurological conditions, specialized testing for biomarkers offers insights into diseases such as Alzheimer's and Parkinson's, supporting early diagnosis and the path to novel treatments. Moreover, in oncology, central labs deliver comprehensive diagnostic and prognostic testing, such as tumor marker analysis and genomic profiling, driving the progression of personalized medicine. Central laboratories' standardized, advanced services are foundational to improving patient outcomes and accelerating medical research across these crucial therapeutic areas.

Regional Insights

In the Americas, the central lab market demonstrates robust growth, fueled by a surge in clinical trial activities and a robust infrastructure for research and development. The rising importance of advanced diagnostics and biomarker development has accelerated the investment for central labs in the Americas. The APAC region stands out for its rapid expansion, driven by increasing investments in healthcare, a growing focus on regulatory compliance, and strategic global partnerships facilitating technology transfer and capability enhancements. A shift toward precision medicine lays the foundation for a dynamic and interconnected global central lab ecosystem for APAC. EMEA showcases an advanced market with stringent regulatory frameworks and a high degree of harmonization in laboratory practices. This region benefits from a history of pharmaceutical research, a highly skilled workforce, and a focus on innovation, particularly in personalized medicine.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Central Lab Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Central Lab Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Central Lab Market, highlighting leading vendors and their innovative profiles. These include ACM Medical Laboratory, Inc., Almac Group, Cerba HealthCare, CROMSOURCE by ClinChoice, Cryoport, Inc., Eurofins Scientific SE, Exagen Inc., Frontage Laboratories, Inc., GBA Group, GCCL Co., Ltd., ICON PLC, InterlabCorp, Intertek Group PLC, IQVIA Inc., LabConnect, Inc., Laboratory Corporation of America Holdings, Lambda Therapeutic Research Ltd., Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd., MDS Pharma Services, Medicover AB, Medpace, Inc., MLM Medical Labs GmbH, Novotech Health Holdings, Pace Analytical Services, LLC, Precision Medicine Group, LLC, Quest Diagnostics Incorporated, REPROCELL Inc., SGS S.A., Shanghai Clinical Research Center, SMS Pharmaceuticals Ltd., Sonic Healthcare International, Syngene International Limited, Thermo Fisher Scientific Inc., Unilabs AB, Versiti, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Central Lab Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Service Type
    • Anatomic Pathology/Histology
    • Biomarker Services
    • Genetic Services
    • Microbiology Services
    • Special Chemistry Services
    • Specimen Management & Storage
  • Phase
    • Phase 1
    • Phase 2
    • Phase 3
  • Therapeutic Area
    • Autoimmune Diseases
    • Cardiovascular Diseases
    • Infectious Diseases
    • Neurology
    • Oncology
  • End-use
    • Academic & Research Institutes
    • Biotechnology Companies
    • Pathology & Diagnostic Lab
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Central Lab Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Central Lab Market?

3. What are the technology trends and regulatory frameworks in the Central Lab Market?

4. What is the market share of the leading vendors in the Central Lab Market?

5. Which modes and strategic moves are suitable for entering the Central Lab Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the number of clinical trials and complexity of drug development activities
      • 5.1.1.2. Government initiatives promoting precision medicine worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of set-up and maintenance of central labs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological integrations and smart features in central labs
      • 5.1.3.2. Investments for establishment and expansion of central labs
    • 5.1.4. Challenges
      • 5.1.4.1. Operational limitations and standardization complexities
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services Type: Preference for central labs for long-term storage of biological samples under controlled conditions for specific management
    • 5.2.2. Phase: Integral role of the central labs for the execution of the entire clinical trial process
    • 5.2.3. End-use: Need to facilitate seamless clinical trials, ensuring data integrity and operational excellence for pharmaceutical companies
    • 5.2.4. Therapeutic Area: Comprehensive diagnostic and prognostic testing for oncology and infectious diseases therapeutic areas
  • 5.3. Market Trend Analysis
    • 5.3.1. Leveraging advanced integration of data analytics for enhanced central lab efficiency across Americas
    • 5.3.2. Significant surge in clinical trials and burgeoning government initiatives for investments and expansions of central lab services across APAC
    • 5.3.3. Stringent regulations concerning biological sample collection for clinical trials and exploration of strategic collaborations between medical laboratories in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Central Lab Market, by Service Type

  • 6.1. Introduction
  • 6.2. Anatomic Pathology/Histology
  • 6.3. Biomarker Services
  • 6.4. Genetic Services
  • 6.5. Microbiology Services
  • 6.6. Special Chemistry Services
  • 6.7. Specimen Management & Storage

7. Central Lab Market, by Phase

  • 7.1. Introduction
  • 7.2. Phase 1
  • 7.3. Phase 2
  • 7.4. Phase 3

8. Central Lab Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cardiovascular Diseases
  • 8.4. Infectious Diseases
  • 8.5. Neurology
  • 8.6. Oncology

9. Central Lab Market, by End-use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biotechnology Companies
  • 9.4. Pathology & Diagnostic Lab
  • 9.5. Pharmaceutical Companies

10. Americas Central Lab Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Central Lab Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Central Lab Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Medpace Central Labs Expand Singapore Facility
    • 13.3.2. Vial Announces Collaborative Alliance with MLM Medical Labs for offering Central Laboratory Solutions
    • 13.3.3. Cerba HealthCare to Acquire Canadian Contract Research Laboratory CIRION BioPharma Research to Expand Bioanalytical Capabilities and Shorten Time-to-Deploy Complex Clinical Trials
    • 13.3.4. Cleveland Clinic and LabConnect announce Strategic Alliance for Improved Patient Care
    • 13.3.5. Versiti Acquires Indiana-based Quantigen for Accelerating Pace of Innovation for Preclinical Research Services
    • 13.3.6. Labor Dr. Wisplinghoff and Labconnect Announce Strategic Alliance - Expanding Global Central Laboratory Services to Accelerate the Development of Medicines
    • 13.3.7. IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
    • 13.3.8. Cerba Research Offers a Customized, Innovative Approach to its Partners in the Laboratory Services
    • 13.3.9. Medpace Central Labs Expand Histology & Anatomic Pathology Services
    • 13.3.10. Thermo Fisher to invest USD 59 Million for Clinical Research Lab Expansion in the U.S.

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CENTRAL LAB MARKET RESEARCH PROCESS
  • FIGURE 2. CENTRAL LAB MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CENTRAL LAB MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CENTRAL LAB MARKET DYNAMICS
  • FIGURE 7. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CENTRAL LAB MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CENTRAL LAB MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CENTRAL LAB MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CENTRAL LAB MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CENTRAL LAB MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CENTRAL LAB MARKET SIZE, BY ANATOMIC PATHOLOGY/HISTOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CENTRAL LAB MARKET SIZE, BY ANATOMIC PATHOLOGY/HISTOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOMARKER SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOMARKER SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CENTRAL LAB MARKET SIZE, BY GENETIC SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CENTRAL LAB MARKET SIZE, BY GENETIC SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CENTRAL LAB MARKET SIZE, BY MICROBIOLOGY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CENTRAL LAB MARKET SIZE, BY MICROBIOLOGY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIAL CHEMISTRY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIAL CHEMISTRY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIMEN MANAGEMENT & STORAGE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIMEN MANAGEMENT & STORAGE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 1, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 1, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 2, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 2, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 3, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 3, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CENTRAL LAB MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CENTRAL LAB MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CENTRAL LAB MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CENTRAL LAB MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CENTRAL LAB MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CENTRAL LAB MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CENTRAL LAB MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CENTRAL LAB MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CENTRAL LAB MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CENTRAL LAB MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CENTRAL LAB MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CENTRAL LAB MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CENTRAL LAB MARKET SIZE, BY PATHOLOGY & DIAGNOSTIC LAB, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CENTRAL LAB MARKET SIZE, BY PATHOLOGY & DIAGNOSTIC LAB, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CENTRAL LAB MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CENTRAL LAB MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 116. AUSTRALIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. AUSTRALIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. CHINA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 124. CHINA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 125. CHINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 126. CHINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 127. CHINA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 128. CHINA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. INDIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 132. INDIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 133. INDIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 134. INDIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 135. INDIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 136. INDIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. INDONESIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 140. INDONESIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 141. INDONESIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 142. INDONESIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 143. INDONESIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. INDONESIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. JAPAN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 148. JAPAN CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 149. JAPAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 150. JAPAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 151. JAPAN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 152. JAPAN CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. MALAYSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 156. MALAYSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 157. MALAYSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 158. MALAYSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 159. MALAYSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 160. MALAYSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 164. PHILIPPINES CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 166. PHILIPPINES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 168. PHILIPPINES CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. SINGAPORE CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 172. SINGAPORE CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 173. SINGAPORE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 174. SINGAPORE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 175. SINGAPORE CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. SINGAPORE CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 180. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 182. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 184. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. TAIWAN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 188. TAIWAN CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 189. TAIWAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 190. TAIWAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 191. TAIWAN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 192. TAIWAN CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. THAILAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 196. THAILAND CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 197. THAILAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 198. THAILAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 199. THAILAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. THAILAND CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. VIETNAM CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 204. VIETNAM CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 205. VIETNAM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 206. VIETNAM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 207. VIETNAM CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 208. VIETNAM CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. DENMARK CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 222. DENMARK CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 223. DENMARK CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 224. DENMARK CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 225. DENMARK CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. DENMARK CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. EGYPT CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 230. EGYPT CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 231. EGYPT CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 232. EGYPT CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 233. EGYPT CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 234. EGYPT CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. FINLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 238. FINLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 239. FINLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 240. FINLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 241. FINLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. FINLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. FRANCE CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 246. FRANCE CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 247. FRANCE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 248. FRANCE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 249. FRANCE CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. FRANCE CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. GERMANY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 254. GERMANY CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 255. GERMANY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 256. GERMANY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 257. GERMANY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 258. GERMANY CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. ISRAEL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 262. ISRAEL CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 263. ISRAEL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 264. ISRAEL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 265. ISRAEL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. ISRAEL CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. ITALY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 270. ITALY CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 271. ITALY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 272. ITALY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 273. ITALY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 274. ITALY CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 278. NETHERLANDS CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 279. NETHERLANDS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 280. NETHERLANDS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 281. NETHERLANDS CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 282. NETHERLANDS CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. NIGERIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 286. NIGERIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 287. NIGERIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 288. NIGERIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 289. NIGERIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 290. NIGERIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. NORWAY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 294. NORWAY CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 295. NORWAY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 296. NORWAY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 297. NORWAY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 298. NORWAY CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. POLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 302. POLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 303. POLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 304. POLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 305. POLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 306. POLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. QATAR CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 310. QATAR CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 311. QATAR CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 312. QATAR CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 313. QATAR CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 314. QATAR CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 315. RUSSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 316. RUSSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 317. RUSSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 318. RUSSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 319. RUSSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 320. RUSSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 321. RUSSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 322. RUSSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 326. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 327. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 328. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 329. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 330. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 335. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 336. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 337. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 338. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 339. SPAIN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. SPAIN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. SPAIN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 342. SPAIN CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 343. SPAIN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 344. SPAIN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 345. SPAIN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 346. SPAIN CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 347. SWEDEN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 348. SWEDEN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 349. SWEDEN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 350. SWEDEN CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 351. SWEDEN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 352. SWEDEN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 353. SWEDEN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 354. SWEDEN CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 355. SWITZERLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. SWITZERLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. SWITZERLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 358. SWITZERLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 359. SWITZERLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 360. SWITZERLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 361. SWITZERLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 362. SWITZERLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 363. TURKEY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 364. TURKEY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 365. TURKEY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 366. TURKEY CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 367. TURKEY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 368. TURKEY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 369. TURKEY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 370. TURKEY CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 371. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 372. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 373. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 374. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 375. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 376. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 377. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 378. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 379. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 380. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 381. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 382. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 383. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018